coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Hyndburn Central PCN, Hyndburn · Health Inequalities Profile

    PCN U96653 · NHS Lancashire and South Cumbria Integrated Care Board · 5 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    50,410

    Registered population

    60.6% aged 18–64

    16.3%

    Aged 65+

    ICB 20.0% · England 17.9%

    18.7%

    Ethnic minority (non-White)

    16.1% Asian · England 9.6%

    66.6%

    In IMD quintile 1

    ICB 30.6% · England 21.0%

    ~28,298

    Core20 residents (est.)

    Resident basis; registered basis ~35,124 · see page 3

    7,800

    Hypertension register

    +2.38% in 3 yrs · England +5.60%

    678

    SMI register

    64% of Hyndburn's

    1,166

    COPD register

    Reviews +9.94% in 3 yrs

    Forecast to 2030

    8,404

    Hypertension patients, 2030

    +604 on today

    74.8%

    QRISK ≥20% on statins, 2030

    +4.83pp over 3 yrs

    3.9%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    48.5%
    Non-frail diabetes and under-80 blood pressure trail.

    Non-frail diabetes HbA1c control is 48.5% (England 57.4%) and under-80 hypertension control is 64.9% (England 67.8%), which could reflect unverified working-age access barriers.

    59.8%
    Asthma reviews and cervical screening lag England.

    Asthma review completion is 59.8% (England 65.7%, leaving about 1,300 register patients unreviewed), while cervical screening aged 25-49 reaches 58.2% (England 66.8%).

    84.3%
    Older hypertension and frail diabetes beat England.

    Blood pressure control aged 80+ reaches 84.3% (England 81.2%) and frail diabetes HbA1c control reaches 83.9% (England 81.9%), demonstrating strong registered-patient delivery.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A younger population with 23.1% aged 0-17 shapes clinical demand across practices

    Across 50,410 registered patients, 23.1% (11,649) are aged 0-17, exceeding Hyndburn (22.2%), the ICB (19.6%), and England (19.6%). Patients aged 65+ comprise 16.3% (8,211), below Hyndburn (16.5%), England (17.9%), and the ICB (20.0%). Census estimates show an Asian or Asian British resident population of 16.1%, above Hyndburn (15.1%), the ICB (9.4%), and England (9.6%), with 39.8% at Arg Healthcare and 30.9% at Richmond Medical Centre. Age figures reflect registered patients, while ethnic estimates derive from area residents.

    Age profile

    0–1723.1%
    18–6460.6%
    65+16.3%

    65+: ICB 20.0%, England 17.9%

    Ethnicity

    White81.3%
    Asian16.1%
    Mixed1.4%
    Other0.9%
    Black0.4%

    Older people · falls rows are Hyndburn local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Hyndburn LA)1,9972,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)83.9%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)48.5%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Hyndburn LA)1,0991,0219552024/25
    Falls deaths, all ages, per 100,000 (Hyndburn LA)14.218.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 deprivation reaches 66.6% across the PCN but divides concentration from absolute volume

    The PCN Core20 cohort is 66.6%, above Hyndburn (54.1%), the ICB (30.6%) and England (21.0%), with an average IMD decile of 2.8. Practice concentration spans 40.3 pp: Arg Healthcare has a 95.8% share (4,605 estimated patients) and Richmond Medical Centre has 93.1% (6,164 estimated patients). By volume, Peel House Medical Practice has 11,016 estimated patients (59.4%) and Oswald Medical Centre has 11,009 (67.8%). Practice estimates sum to 35,124 registered patients, whereas area resident counts total 28,298; reconciling these different denominators is required before committing outreach resources.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Arg Healthcare95.8% · 4,605 patients
    Richmond93.1% · 6,164 patients
    Oswald67.8% · 11,009 patients
    Peel House59.4% · 11,016 patients
    Accrington55.5% · 2,330 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    678

    SMI register

    1.38% recorded prevalence

    447

    Learning disability register

    0.91% recorded prevalence

    30

    Care homes, 879 beds

    In the PCN catchment

    10.2%

    Provide unpaid care

    Hyndburn, Census 2021

    Recorded prevalence is 0.9% for learning disability (447 patients) and 1.4% for severe mental illness (678 patients), alongside 30 catchment care homes with 879 beds. Hyndburn borough data show a 10.2% unpaid carer rate and 2 people sleeping rough in autumn 2025, which cannot be directly extrapolated to PCN practice lists.

    Severe mental illness: physical health checks

    For severe mental illness, annual blood pressure checks reach 77.7% (England 83.4%), with Richmond Medical Centre at 67.7%, and BMI recording reaches 72.5% (England 82.1%) across 678 registered patients.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    7,800

    Hypertension register

    +2.38%

    Register growth, 3 yrs

    Hyndburn +2.89% · England +5.60%

    +0.59pp

    BP control, under 80

    ≤140/90 · +1.28pp aged 80+

    +604

    More patients by 2030

    Forecast 8,404 (16.68%)

    Hypertension case-finding and control

    Recorded hypertension prevalence is 15.9% (7,800 patients), above England (15.2%) but below Hyndburn (16.4%) and the ICB (17.2%). Among patients aged 80 and over, blood pressure control reaches 84.3%, exceeding England (81.2%) and the ICB (81.8%). Conversely, control under 80 is 64.9%, trailing England (67.8%), Hyndburn (66.4%) and the ICB (67.1%). Overall treatment to target is 68.8% (England 70.3%). This divergence could reflect working-age access barriers, which an audit would test. Under-80 blood pressure control lags comparators while older cohorts exceed them, indicating that targeted recall and flexible review access for working-age patients should be prioritised.

    Lipids and statins

    For primary CVD prevention in diabetes aged 40 and over, statin coverage is 70.6%, trailing England (73.2%) and the ICB (71.3%). Conversely, secondary prevention in diabetes with CVD reaches 86.8% (England 84.4%), while QRISK 20% or higher treatment is 63.9% (England 63.6%). Primary prevention in diabetes lags national rates, indicating scope to review statin prescribing.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026106,611£1.40£1.64£1.86£149,255
    Cardiovascular (all), 2025141,025£2.97£3.38£3.33£418,844

    In 2026, the PCN prescribed 106,611 lipid-regulating items at £1.40 per item, below England (£1.86) and the ICB (£1.64), spending £49,041 less than England's unit cost and £25,587 less than the ICB's. Lower unit cost indicates spending is below national and ICB averages across captured items.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +20.19%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −6.49%

    Asthma prevalence, PCN 3-yr % change

    Over 2023 to 2025, asthma reviews rose +20.2% (England +4.4%), yet current review completion is 59.8% (England 65.7%), leaving about 1,300 register patients unreviewed. Second-hand smoke recording for patients aged 6-19 is 66.9% (England 78.8%), while asthma prescribing in ages 5-19 is 1,620 per 1,000 (England 1,488). Meanwhile, COPD reviews reached 71.7% (England 76.4%) and the COPD register fell 2.3% over 2023 to 2025 (England +2.6%).

    Cancer register and children's immunisation

    Childhood immunisations in Q1 2025/26 trail the 95.0% target: 6-in-1 at 12 months is 83.1% (England 91.0%), age-5 4-in-1 booster is 76.7% (England 80.9%, 18.3 pp below target), and age-5 MMR shows an 8 pp contrast between dose 1 (90.0%) and dose 2 (82.0%, England 82.8%). Cancer prevalence is 3.4% (England 3.8%), with 1,676 patients. Lower pre-school uptake could leave cohorts vulnerable to preventable infection.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months83.1%

    England 91.0%

    6-in-1 complete primary course at 24 months87.3%

    England 92.2%

    MMR dose 1 at 24 months84.1%

    England 88.3%

    MMR dose 2 at age 582.0%

    England 82.8%

    4-in-1 pre-school booster at age 576.7%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    52.4%

    Lancashire and South Cumbria ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,010

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Lancashire and South Cumbria ICBEnglandNo usable stageStaged cancers
    Breast86.0%85.4%6%1,561
    Prostate42.4%53.2%11%1,404
    Lung31.1%33.8%15%1,374
    Bowel44.2%47.0%13%1,198
    Skin cancer86.1%87.8%21%519

    In 2022, 52.4% of staged cancers (4,642 of 8,863) across NHS Lancashire and South Cumbria ICB were diagnosed at stage 1 or 2, trailing England (55.3%) and 22.6 pp below the 75.0% national ambition by 2028, with known stage recorded for 74.6% (8,863 of 11,883). Reaching 75.0% across the ICB would require about 2,010 extra early-stage diagnoses annually; staging is not captured at PCN level. PCN cervical screening coverage aged 25-49 is 58.2% (England 66.8%), dropping to 48.2% at Richmond Medical Centre and 54.2% at Oswald Medical Centre. Breast screening aged 53-70 is 66.6% (England 69.9%). Lower PCN screening coverage may constrain opportunities to detect early-stage cancer.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In Jul 2026 (provisional), East Lancashire Hospitals NHS Trust achieved 73.2% against the 85.0% 62-day cancer referral to treatment standard, ahead of England (71.2%) but behind the ICB (73.6%), Lancashire Teaching Hospitals NHS Foundation Trust (75.0%) and Northern Care Alliance NHS Foundation Trust (78.6%). The trust met the 75.0% 28-day faster diagnosis standard at 81.5% and the 96.0% 31-day combined treatment standard at 98.1%. Diagnostic waits over 6 weeks at the trust were 0.4% for MRI and 0.1% for CT. These figures are consistent with prompt secondary care diagnostic turnaround alongside wider 62-day pathway delays.

    Pathways within standard (%)East LancashireNorthern Care AllianceLancashireLancashire and South Cumbria ICBEngland
    28-day faster diagnosis (75%)81.5075.2082.9078.3979.32
    31-day treatment (96%)98.1194.5489.4393.6292.50
    62-day referral to treatment (85%)73.1678.6575.0473.6271.16
    Diagnostic waits over 6 weeks (%)East LancashireNorthern Care AllianceLancashireEngland
    MRI0.435.092.4121.40
    CT0.154.1014.979.92
    Echocardiography0.0031.4813.8528.48
    Colonoscopy0.9540.040.0030.83
    Gastroscopy1.1636.480.0029.02
    All 15 DM01 tests3.2515.7126.6523.14
    Community services activityLancashire residentsLancashire and South Cumbria ICB
    Care contacts126,445193,720
    Referrals20,41529,855
    Patients with a contact47,32065,335

    Community services (residents of Lancashire), Jun 2026 (provisional). In Jun 2026 (provisional), 56.9% of community service contacts for Hyndburn borough residents (72,000 of 126,445) involved adults aged 65+, describing borough-wide system activity rather than PCN performance. These borough-level contacts reflect wider system engagement with older residents rather than PCN-specific delivery.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Phone access spans 39.0 pp across practices despite high clinical QOF achievement

    In 2025/26, practice clinical QOF achievement ranged from 92.0% at Arg Healthcare to 100.0% at Richmond Medical Centre (England 97.1%). Conversely, vaccination and immunisation achievement trailed England (55.2%), spanning 15.6% at Accrington Victoria GP Practice and Richmond Medical Centre to 28.5% at Arg Healthcare (a 12.9 pp spread).

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Peel House9059.450.1%62.8%78.3%
    Oswald9367.859.1%76.4%74.6%
    Arg Healthcare8495.865.3%73.6%71.0%
    Accrington12855.532.8%73.9%61.0%
    Richmond9393.126.3%76.8%50.5%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNHyndburnAssetPCNHyndburn
    Care homes (catchment)30 (879 beds)n/aSchools (catchment)56n/a
    Children's centres67Places of worship4555
    Libraries35Primary schools (LA maintained)2426
    Primary academies67

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Asthma annual review recall

    Asthma annual review completion is 59.8% (England 65.7%, ICB 65.0%), leaving 1,316 (about 1,300) of 3,274 register patients unreviewed; age 6-19 second-hand smoke recording is 66.9% (England 78.8%). For discussion: run a single-template asthma recall offering after-school and extended-hours slots, pairing concentration outreach with high-volume clinics. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    SMI physical health check outreach

    Across 678 SMI register patients, annual blood pressure checks reach 77.7% (England 83.4%, ICB 79.8%; 67.7% at Richmond Medical Centre) and BMI recording is 72.5% (England 82.1%, ICB 76.8%). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Working-age hypertension and diabetes review

    With 7,800 on the hypertension register, under-80 BP control is 64.9% (England 67.8%, ICB 67.1%); non-frail diabetes HbA1c <=58 mmol/mol in 2024/25 is 48.5% (1,405 of 2,898; England 57.4%). For discussion: test pharmacist-led recall, remote blood pressure monitoring and extended-hours diabetes and hypertension clinics for working-age patients. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Tailored ethnic minority health engagement (p2)Asian / Asian BritishNeighbourhood health framework · Core20PLUS5 approachPCN
    Two-track Core20 outreach (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Physical health check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Working-age hypertension recall audit (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Preschool booster recall (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening recall audit (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Primary care telephony access review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Asthma annual review recall (p12)Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) · Patients with Asthma (6-19 yrs): Second-hand smoking status recorded in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · SMI physical health check outreach (p12)Severe mental illness register · SMI register with a BP check in the last 12 months · SMI register with a BMI recorded in the last 12 monthsMHIS · From Harm to HopePCN & Practice
    Option 3 · Working-age hypertension and diabetes review (p12)Hypertension register · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) · Last BP reading of patients (80+ yrs with hypertension) in the last 12 months is <= 150/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026ICB2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15